首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of drug delivery science and technology

缩写:J DRUG DELIV SCI TEC

ISSN:1773-2247

e-ISSN:2588-8943

IF/分区:5.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引88条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Bommanahalli Nagaraju Kumara,Anuj Chauhan Bommanahalli Nagaraju Kumara
Purpose: Cataract surgery is commonly followed by daily administration of multiple eye-drops of antibiotics and anti-inflammatory drugs such as moxifloxacin, dexamethasone and bromfenac. Drop-less cataract surgery elimina...
Luca Morici,Sébastien Jenni,Bill Hakim et al. Luca Morici et al.
Osteoarthritis is the most common degenerative joint disease worldwide, yet no intra-articular disease-modifying osteoarthritis drugs (DMOADs) have succeeded in clinical trials due to poor therapeutic outcomes and limited cartilage targetin...
Federico Machinandiarena,Domenico D&#x;Atri,Lisa M Jenkins et al. Federico Machinandiarena et al.
RNA therapy, which includes delivery of mRNA or siRNA, shows promise for treating various diseases, but difficulties in targeting specific cell types and low efficiency of loading RNA into nanoparticles remain hurdles to achieving widesprea...
Weizhou Yue,Tianqi Wang,Lingxiao Xie et al. Weizhou Yue et al.
Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. Despite aggressive surgical and medical treatments, the prognosis for patients with GBM remains grim and tumor recurrence is inevitable. Long-acting localize...
Paras Mani Giri,Arpita Ghosal,Travis Kruse et al. Paras Mani Giri et al.
Panobinostat is a highly active and potent non-selective histone deacetylase inhibitor (HDACi) that demonstrates significant anticancer activity against various cancers, including pancreatic cancer. However, like other HDAC inhibitors, its ...
Sheriff Umar,Jonathan Catazaro,James Wachira et al. Sheriff Umar et al.
Gemcitabine is a powerful anticancer antimetabolite drug which is usually administered as hydrochloride salt (GemHCl), but its systemic administration is accompanied by the undesirable "burst" phenomenon and its adverse side effects. To avo...
Klaudi K Vaiphei,A Prabakaran,Singh Snigdha et al. Klaudi K Vaiphei et al.
Tamoxifen (TMF) is an anticancer agent used for managing estrogen receptor-positive breast cancer. It has limited therapeutic efficacy against breast cancer, which could be enhanced by the coadministration of herbal drugs like piperine (PIP...
Matthew T Freeman,Arianne Parvaresh-Rizi,Samantha A Meenach Matthew T Freeman
Macrophages are an integral part of the innate immune system and act as a first line of defense to pathogens; however, macrophages can be reservoirs for pathogens to hide and replicate. Tuberculosis, influenza virus, and severe acute respir...
Anthony J Kyser,Bassam Fotouh,Victoria Harris et al. Anthony J Kyser et al.
Whether it be due to genetic variances, lack of patient adherence, or sub-optimal drug metabolism, the risk of antibiotic resistance from medications administered systemically continues to pose significant challenges to fighting infectious ...
Marco Vigo,Elena Haro-Martínez,Eloy Ruiz et al. Marco Vigo et al.
Intercellular adhesion molecule 1 (ICAM-1) is a cell-surface protein actively explored for targeted drug delivery. Anti-ICAM-1 nanocarriers (NCs) target ICAM-1-positive sites after intravenous injection in animal models, but quantitative me...